Next Article in Journal
The Effects of Reactant Concentration and Air Flow Rate in the Consumption of Dissolved O2 during the Photochemistry of Aqueous Pyruvic Acid
Previous Article in Journal
Chemical and Sensory Characterization of Cabernet Sauvignon Wines from the Chinese Loess Plateau Region
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 24
Issue 6
10.3390/molecules24061123
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application

by
Dong Xu
,
Meng-Jiao Hu
,
Yan-Qiu Wang
and
Yuan-Lu Cui
*
Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(6), 1123; https://doi.org/10.3390/molecules24061123
Submission received: 6 March 2019 / Revised: 18 March 2019 / Accepted: 19 March 2019 / Published: 21 March 2019
Browse Figures
Review Reports Versions Notes

Abstract

:
Quercetin is a bioactive compound that is widely used in botanical medicine and traditional Chinese medicine due to its potent antioxidant activity. In recent years, antioxidant activities of quercetin have been studied extensively, including its effects on glutathione (GSH), enzymatic activity, signal transduction pathways, and reactive oxygen species (ROS) caused by environmental and toxicological factors. Chemical studies on quercetin have mainly focused on the antioxidant activity of its metal ion complexes and complex ions. In this review, we highlight the recent advances in the antioxidant activities, chemical research, and medicinal application of quercetin.

Graphical Abstract

1. Introduction

Quercetin (Figure 1a,b) is a polyphenolic flavonoid compound [1]. It is abundantly present in kales, onions, berries, apples, red grapes, broccoli, and cherries, as well as tea and red wine [2,3]. Modern studies have shown that quercetin prevents various diseases, such as osteoporosis, some forms of cancer, tumors, and lung and cardiovascular diseases. The antioxidant effects of quercetin play a significant role in the prevention and treatment of such diseases [4]. Moreover, owing to its high solubility and bioavailability, quercetin may also exhibit strong antioxidant activity after forming a complex or combining to form some novel preparations used for human health care [5,6,7,8]. At the same time, according to the bibliometric analysis results based on the Web of Science database (Figure 1c), the antioxidant property of quercetin has become a research hotspot [9,10]. Yet, there have been few reviews and summaries focusing on the antioxidant activity of quercetin in recent years [11,12]. Therefore, this paper discusses the antioxidant effects of quercetin from two aspects, biological activity and chemical research, and provides a guideline for the research direction regarding the antioxidant effects of quercetin. In addition, this review describes the application of antioxidants in the medicinal field. This review aims to provide some guidance and reference for future antioxidant research on quercetin.

2. Antioxidant Activity of Quercetin In Vivo

The antioxidant activity of quercetin is mainly manifested through its effect on glutathione (GSH), enzymatic activity, signal transduction pathways, and reactive oxygen species (ROS) caused by environmental and toxicological factors. Quercetin shows a strong antioxidant activity by maintaining oxidative balance.

2.1. Direct Effects of Quercetin on GSH

Quercetin increases the body’s antioxidant capacity by regulating levels of GSH. This is because, once oxygen free radicals are generated in the body, superoxide dismutase (SOD) quickly captures O2- and transforms it into H2O2. This enzyme further catalyzes the decomposition of H2O2 to the non-toxic H2O. This reaction requires GSH as a hydrogen donor. Animal and cell studies found that quercetin induces GSH synthesis [13,14]. It was also found that the application of quercetin therapy in renal ischemia/reperfusion (I/R) increased GSH levels, an effect that enhanced the antioxidant capacity of rats [15]. When quercetin is applied at high doses, the dynamic balance of GSH (under the action of GSH peroxidase) is affected; H2O2 is converted to H2O and GSH is oxidized to GSSG (oxidized glutathione disulfide). GSH reductase catalyzes the reduction of GSSG in the liver and red blood cells (by providing H) to form GSH. Thus, the dynamic balance of GSH is produced, which may cause the inhibition of GSH levels in low doses. This inhibition of quercetin on GSH at the level of 0.5% is reported in the literature [16].

2.2. Effects of Quercetin on Enzymatic Activity

The –OH groups on the side phenyl ring of quercetin are bound to important amino acid residues at the active site of two enzymes. In this way, it has a stronger inhibitory effect against key enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), which are associated with oxidative properties [17]. Quercetin has been shown to alleviate the decline of manganese-induced antioxidant enzyme activity, the increase of AChE activity, hydrogen peroxide generation, and lipid peroxidation levels in rats, thereby preventing manganese poisoning [18].
It was reported that pretreatment with quercetin significantly enhanced the expression levels of endogenous antioxidant enzymes such as Cu/Zn SOD, Mn SOD, catalase (CAT), and GSH peroxidase in the hippocampal CA1 pyramidal neurons of animals suffering from ischemic injury. This indicates that it strongly protects the hippocampal area CA1 pyramidal neurons from I/R injury. Thus, quercetin may be a potential neuroprotective agent for transient ischemia [19].
In addition, as one of the most metabolically active tissues of the body, bone undergoes a continuous and complex remodeling process throughout life. In particular, osteoblasts, which are derived from osteoprogenitor cells produced by self-renewing, pluripotent stem cells, play a critical role in this cycle. The primary function of osteoblasts is to generate a new bone matrix and, together with osteocytes, support the bone structure itself. Damage to osteoblasts can therefore result in several dysfunctions. Smokers have low bone mass and stability. It was reported that the application of quercetin can promote fracture healing in smokers by removing free radicals and upregulating the expression of heme-oxygenase- (HO-) 1 and superoxide-dismutase- (SOD-) 1, which protects primary human osteoblasts exposed to cigarette smoke [20].
Quercetin has also been shown to prevent heart damage by clearing oxygen-free radicals caused by lipopolysaccharide (LPS)-induced endotoxemia. LPS induces histopathological and biochemical damages to the myocardium in endotoxemia model. In a rat model experiment, rats treated with LPS showed a significant increase in the malondialdehyde (MDA) level in tissues and a decrease in SOD and CAT activity in heart tissues. In contrast, quercetin treatment increased the levels of SOD and CAT and reduced the level of MDA after LPS induction, suggesting that quercetin enhanced the antioxidant defense system [21].

2.3. Effects of Quercetin On Signal Transduction Pathways

Quercetin has several effects on various signal transduction pathways, such as activating, inhibiting, upregulating, or downregulating many molecules of the body. In this way, quercetin can improve the antioxidant state of the body and repair injury such as spinal cord injury, atherosclerosis, and lead or cadmium toxicity. Figure 2 shows the antioxidant signal pathways regulated by quercetin.
By influencing signal transduction pathways, quercetin modulates the enzymes or antioxidant substances that enhance antioxidant properties, thereby preventing disease development. Studies have shown that the protective mechanism of quercetin against acute spinal cord injury is mediated by its inhibitory effect on the p38MAPK/iNOS signaling pathway, the downregulation of MDA levels, and the upregulation of SOD activity to promote antioxidant activity [27]. In psoriasis, it was found that quercetin promotes disease recovery by downregulating the expression of NIK and NF-κB including IKK and RelB, and upregulating the expression of TRAF3. It also increases the activity of GSH, CAT, and SOD, and decreases MDA levels in skin tissues induced by imiquimod (IMQ), which collectively enhance the body’s antioxidant performance [28].
Several enzymes regulate signaling pathways to enhance antioxidant activities, such as oxidative stress protection. Quercetin reversed the oxLDL-induced decrease in AMPK activation and oxLDL-induced increase in NADPH oxidase expression, thereby maintaining AKT/eNOS function and suppressing NF-κB signal transduction to combat atherosclerosis [29]. Moreover, it can promote oxidation or enhance antioxidant capacity by modulating signal pathways. For example, quercetin controls the development of atherosclerosis induced by a high-fructose diet by inhibiting ROS and enhancing PI3K/AKT. It also promotes the functional recovery of moving medium after cerebral ischemia by promoting antioxidant signal transduction, increasing resistance to apoptosis, and transforming the TGFβ-2/PI3K/AKT pathway [30,31,32]. In humans, quercetin can also prevent or treat damage or toxicity by directly enhancing antioxidant properties through signal transduction pathways, as shown in Table 1.

2.4. Effects of Quercetin on ROS Caused by Environmental and Toxicological Factors

Oxidative damage is mostly caused by ROS. Quercetin can remove ROS, thereby resisting oxidative damage such as respiratory damage, ultraviolet radiation b (UVB) skin lesions caused by radiation, and oxidative damage induced by paraquat, as well as sperm change associated with ROS and oxidative damage of gastric epithelial cells.
Respiratory damage is caused by exposure to fine particulate matter (PM2.5) in the environment, leading to the cellular activity of 16HBE cells, increased production of ROS, and the inhibition of the expression of mitochondrial genes. It has been recognized that quercetin may stimulate 16HBE cells to repair oxidative damage after exposure to PM2.5 by regulating ROS production and anti-inflammatory processes [44].
Human skin is the body’s largest organ that can resist all kinds of environmental damage. However, UVB induces a transient increase in ROS and an imbalance of endogenous antioxidant systems, thereby increasing the level of free radicals and inflammation, which affect cellular processes. Studies have shown that quercetin prevents UVB-induced radiation damage by removing ROS and strengthening the cell membrane and mitochondrion against ROS-induced damage. In addition, it also inhibits cell membrane mobility and mitochondrial membrane depolarization. Therefore, the consumption of quercetin also inhibits this imbalance and is used to prevent UVB-induced skin damage [45,46].
Quercetin prevents oxidative damage induced by paraquat by reducing the ROS levels and increasing the total GSH levels. Other studies have shown that quercetin can alleviate oxidative stress by modulating the expression of antioxidant-related genes in A549 cells [47]. Gastric epithelial injury caused by ROS such as H2O2 can be suppressed by quercetin treatment due to its protective effects on gastric epithelial GES-1 cells. In these cells, quercetin prevents oxidative damage and inhibits the production of ROS during acute gastric mucosal injury in mice [48]. Moreover, since quercetin has a strong scavenging capacity for ROS, it also protects sperm from ROS and maintains the function of male germ cells [49].
On the other hand, quercetin inhibits oxidative stress, thereby preventing antioxidant damage. Oxidative stress is caused by the imbalance between oxidants and antioxidants in the body, and it tends to be oxidized. Once oxidized, it results in neutrophil inflammatory infiltration, high protease secretion, and other oxidative intermediates. Quercetin inhibits oxidative stress by regulating the balance between oxidant and antioxidant effects. In various experimental studies, quercetin suppressed radiation-induced brain damage in rats, oxidative damage in rats induced by acrylamide, nerve damage in retinas of diabetic rats, as well as neurodegenerative diseases and oxidative stress induced by cadmium fluoride. By modulating the antioxidant levels, quercetin protects the brain, nerves, or other cells in the body from damage caused by oxidation [50,51,52,53,54].
Ionizing radiation induces various types of damage by increasing free radical formation or increasing cell damage and cell death due to ROS. Quercetin effectively protects cells from genetic toxicity and damage induced by radiation by scavenging free radicals and increasing endogenous antioxidant levels. Bioflavonoids act as reducing agents for hydrogen or electronic agents, which inhibit or reduce free radical toxicity and enhance antioxidant properties in the body, thereby providing protection against radiation [55,56,57].
Quercetin exerts antioxidant and hepatoprotective effects against acute liver injury in mice induced by tertiary butyl hydrogen peroxide. This is attributed to its strong antioxidant effect and free radical scavenging effect. It inhibits lipid peroxidation and increases antioxidant activity and thus can be an effective treatment for oxidative liver injury [58]. Quercetin has been found to directly remove ROS and hydroxyl radicals in hypoxia and restore endogenous redox homeostasis by increasing glutathione levels and removing free radical enzyme systems. In this way, it reverses hypoxia-induced memory impairment by reducing oxidative stress-induced neurodegeneration in the hippocampus [59].
Quercetin removes free radicals and strengthens antioxidant defense systems in the body. Thus, quercetin can suppress oxidative stress including the production of ROS induced by nicotine to treat diseases such as tobacco addiction [60].

3. Chemical Studies on the Antioxidant Activity of Quercetin

Due to the poor water solubility and low bioavailability (5.3%) of quercetin, several studies have been performed to modify its structure to increase its water solubility and bioavailability, and thus enhance its antioxidant activity [61].
The modification process of quercetin is generally divided into two types—namely, the derivation of quercetin or recombination with other active groups. The former changes the structure of quercetin and improves its solubility through derivation, while the latter produces a synergistic effect based on the properties of active groups and quercetin, such as metal complexes of quercetin. Moreover, the bioactivity and pharmacological action of quercetin are significantly enhanced after forming complexes with some metal or complex ions. Therefore, many researchers have attempted to improve the antioxidant activity of quercetin using the complex formation method.

3.1. Complexes with Metal Ions

Combining quercetin with metal ions improves the reducibility of flavonoids by enabling them to be oxidized by free radicals more easily compared to unmatched flavonoids. Therefore, when complexed with metal ions, quercetin shows excellent antioxidant activity. The scavenging capacity of quercetin combined with vanadium [62], copper [63,64], magnesium [65], iron [66], ruthenium [67], cobalt and cadmium [68], calcium [69], and rare earth elements [70] is stronger compared to pure quercetin, based on the DPPH free radical scavenging test. This implies that the antioxidant activity of quercetin complexes is significantly higher than that of pure quercetin. Most of these complexes have been applied in medicine. For instance, the vanadium quercetin complex weakens mammary cancer by regulating the p53 and Akt/mTOR pathways and downregulating cellular proliferation together with increasing apoptosis events. The ruthenium–quercetin complex induces apoptosis in colon cancer cells through a p53-mediated pathway and promotes antiangiogenic activity by inhibiting vascular endothelial growth factor (VEGF). The solid–quercetin rare earth (III) complexes display strong inhibition in tumor cells compared with pure quercetin. Additional studies are required to explore the therapeutic potential and application of other quercetin complexes. However, when quercetin is combined with some metal ions, such as lead [71] and terbium [72], its free radical scavenging and total antioxidant activity are reduced.

3.2. Complexes with Complex Ions

A study reported that quercetin does not enhance the activity of SOD, CAT, and GSH-PX in ARPE-19 cells treated with H2O2 and does not effectively reduce the amount of ROS and MDA in ARPE-19 cells. However, a quercetin–phospholipid complex significantly increased the activity of these enzymes and significantly reduced ROS and MDA levels. These datasets show that the antioxidant activity of quercetin–phospholipid complexes is higher compared to that of free quercetin. The poor water solubility of quercetin limits its use. Therefore, a quercetin–phospholipid complex was developed to improve its water solubility, enhance its absorption through the gastrointestinal tract, and increase its bioavailability [73,74]. The bioavailability of quercetin has also been increased by structural modification with glucoside–sulfate conjugates. Studies have shown that after oral administration of quercetin, about 93.3% of quercetin is metabolized in the intestinal tract and only 3.1% is metabolized in the liver. In contrast, when its structure is altered by forming glucoside–sulfate conjugates, no significant intestinal liver recirculation is observed for the metabolites of quercetin and its conjugates. This indicates that the bioavailability of free quercetin is improved after the incorporation of conjugates, which further enhances the antioxidant activity of free quercetin.
Some complex ionic complexes, such as glucan–quercetin conjugate [75], calcium phosphate–quercetin nanocomplex (CPQN) [76], and quercetin–germanium nanoparticles [77], have higher antioxidant activity than free quercetin. Similar to quercetin complexes with metal ions, complexes with complex ions have been applied in medicine and other pharmaceutical fields.

4. Application of Antioxidant Activity in the Medicinal Field

Given the clinical importance of oxidative damage, antioxidants are expected to treat some diseases. Therefore, quercetin can be exploited in medicinal field due to its strong antioxidant properties. This basic principle of antioxidant activity of quercetin is shown in Figure 3.

4.1. Effects of Quercetin on Tumors

Quercetin has been found to influence malignant tumors such as tumors of epithelial tissue and malignant tumors of interlobular tissue. The term "cancer" generally refers to all malignant tumors, including cancer and sarcoma.
Quercetin has been used in cancer prevention and to prevent the spread of various cancers, such as lung, prostate, liver, breast, colon, and cervical cancers. Its anticancer properties are mediated by various mechanisms involving cell signaling pathways and enzymatic activities that inhibit carcinogens. Here, we discuss the treatment or prevention aspect of quercetin for cancer.
High levels of ROS induce oxidative stress, which in turn causes the over-activation of signal transduction pathways and promotes cell proliferation, as well as survival and metabolic adaptation to the tumor microenvironment. In this way, ROS promotes tumorigenesis. Quercetin regulates both internal and external pathways of ROS-mediated protein kinase C (PKC) signaling. PKC is a key regulator of cell growth and differentiation in mammalian cells and its activation partially depends on ROS signaling. PKC inhibits cell proliferation and survival and induces apoptosis in cancer cells. Quercetin prevents cancer development by upregulating p53, which is the most common inactivated tumor suppressor. It also increases the expression of BAX, a downstream target of p53 and a key pro-apoptotic gene in HepG2 cells [82,83].
In addition, quercetin prevents cancer by modulating oxidative stress markers and antioxidant enzymes. In a previous study, histology and oxidative stress markers such as lipid peroxidation (LPO), H2O2, and antioxidant GSH level were measured in rats. The result showed that rats treated with carcinogen and testosterone had higher levels of LPO and H2O2 and lower levels of GSH compared to quercetin-treated rats. This implies that quercetin may be used to target signaling molecules in prostate cancer, which is the second highest cause of cancer-related deaths in men [84]. Other studies have confirmed that the levels of antioxidant enzymes and apoptosis proteins in animals with prostate cancer are increased by treatment with quercetin. Studies have found that insulin-like growth factor receptor 1 (IGFIR), AKT, androgen receptor (AR), and cell proliferation and anti-apoptotic proteins are increased in cancer, but quercetin supplementation normalizes their expression [85]. Moreover, quercetin significantly increases antioxidant enzyme levels, including GSH, SOD, and CAT, and inhibits lipid peroxides, thereby preventing skin cancer induced by 7,12-dimethyl Benz (a) anthracene (DMBA) and croton oil in mice. Histology and enzyme activity tests suggest that oral quercetin in the daily diet may decrease the development of skin cancer [86].

4.2. Effects of Quercetin on Heart Diseases

Based on its antioxidant activity, quercetin has a therapeutic effect on cardiovascular diseases. For instance, coronary heart disease may lead to acute myocardial infarction (AMI). A recent study showed that oxidative stress is an important factor involved in the development of AMI. Quercetin significantly decreases MDA content, increases SOD and CAT activity, and regulates anti-inflammatory and anti-apoptosis processes to effectively protect against myocardium injury [87]. In addition, quercetin protects the heart from secondary cardiac dysfunction due to oxidative stress and inflammation. Quercetin significantly attenuates ROS overproduction, decreases trauma-induced damage, increases TNF-α, and prevents Ca2+ overload-induced myocardial cell injury. Therefore, quercetin can efficiently prevent injury induced by oxidative stress [88].

4.3. Effects of Quercetin on Depression

Depression is a common mental disease that negatively affects human physical and mental health. Chronic stress is connected with depression and anxiety. Several studies have shown that quercetin treatment significantly lowers oxidative and inflammatory stress and prevents neural damage by regulating oxidative stress markers such as TBARS and nitric oxide, antioxidants such as total thiol and catalase, and pro-inflammatory cytokines in the hippocampus [89]. Elsewhere, it has been shown that quercetin has a significant antidepressant effect on the olfactory bulbectomy (OB), an animal model of depression. In a forced swimming test and tail suspension test, quercetin reduced the immobility time, increased the time spent grooming, and increased the SOD activity and lipid hydroperoxide content (LOOH) in the hippocampus, thus providing antidepressant effects [90]. These findings indicate that quercetin prevents stress induced by neurological complications and enhances the total antioxidant activity in the body.

4.4. Effects of Quercetin on Diseases Caused by Poisoning

Quercetin has the potential to treat diseases caused by pathogenic factors. Such diseases are often caused by an imbalance between oxidation and antioxidation processes. Quercetin protects the body from urotoxicity induced by cyclophosphamide (CYP) via the inhibition of oxidative stress and the restoration of pro-inflammatory/anti-inflammatory cytokine balance. Compared with normal group, CYP treatment showed a marked reduction in bladder levels of catalase, SOD, and IL-10. However, quercetin prevented urotoxicity by reversing the changes in these biochemical markers and histopathology [91]. By inhibiting CYP 2E1 activity, quercetin reduces the production of ROS and peroxide oxidation, which prevents liver injury in type I diabetes [92]. In addition, quercetin exerts therapeutic effects on diseases induced by manganese [93], ciprofloxacin [94], glycosides from thunder god vine [95], cadmium (Cd) [96], Procarbazine (PCZ) [97], arsenic [98], LPS [99], and cisplatin (Cis.) [100]. Quercetin can treat diseases caused by oxidative damage by increasing the body’s total antioxidant activity and related antioxidant enzymes.

4.5. Effects of Quercetin on Other Diseases

Numerous studies have shown that quercetin has the potential to treat other diseases, such as necrotizing enterocolitis (NEC), diabetes, and lung injury. In NEC, quercetin modulates the total antioxidant status by regulating serum levels of MDA and GSH [101]. In type II diabetes, a study found that quercetin intake was inversely related to the prevalence of diabetes [102]. Quercetin has been proposed to be a remedy for idiopathic pulmonary fibrosis (IPF) due to its capacity to restore pulmonary redox balance and suppress inflammation [103]. Quercetin prevents acute lung injury by reducing the levels of oxidative stress markers and increasing antioxidant enzyme activities [104].

5. Conclusions

Quercetin is a typical flavonoid that is abundant in fruits and vegetables. Its application in the medicinal field has shown potential to improve human health due to its antioxidant activity in vivo. Some studies show that quercetin can be used as a nutraceutical to offer protection against various diseases. It is effective in the treatment and prevention of human diseases since it influences glutathione, enzymes, signal transduction pathways, and ROS production. However, its application in the pharmaceutical field is limited by its low absorption into the body based on its poor solubility, low bioavailability, poor permeability, and instability. When it forms complexes with metal ions or complex ions, its bioavailability and antioxidant effect are enhanced and strengthened. In addition to quercetin complexes, newer preparations of quercetin have emerged in recent years, including nanoparticles loaded with quercetin [105,106,107], polymeric micelles of quercetin [108], quercetin-loaded mucoadhesive nanoemulsion [109], quercetin-loaded gel [110], and others [111,112]. These preparations improve the solubility and bioavailability of quercetin, which enhances its clinical efficacy and offers new drug formulations for research and development.
Therefore, strategies that improve the solubility and bioavailability of quercetin will potentiate its properties such as its antioxidant and antimicrobial activities. This will contribute to the full exploitation of quercetin as a rich natural drug resource for medicinal uses.

Funding

This work was supported by the National Natural Science Foundation of China (81741119).

Acknowledgments

The authors are thankful to Tianjin University of Traditional Chinese Medicine for help in conducting this study.

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Rauf, A.; Imran, M.; Khan, I.A.; Ur-Rehman, M.; Gilani, S.A.; Mehmood, Z.; Mubarak, M.S. Anticancer potential of quercetin: A comprehensive review. Phytother. Res. 2018, 32, 2109–2130. [Google Scholar] [CrossRef] [PubMed]
  2. Almeida, A.F.; Borge, G.I.A.; Piskula, M.; Tudose, A.; Tudoreanu, L.; Valentova, K.; Williamson, G.; Santos, C.N. Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation. Compr. Rev. Food Sci. Food Saf. 2018, 17, 714–731. [Google Scholar] [CrossRef] [Green Version]
  3. Anand David, A.V.; Arulmoli, R.; Parasuraman, S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn. Rev. 2016, 10, 84–89. [Google Scholar] [PubMed] [Green Version]
  4. Boots, A.W.; Haenen, G.; Bast, A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325–337. [Google Scholar] [CrossRef]
  5. Xie, X.; Shen, Q.; Cao, L.; Chen, Y.; Ma, L.; Xiao, Q.; Yu, C.; Fu, Z. Depression caused by long-term stress regulates premature aging and is possibly associated with disruption of circadian rhythms in mice. Physiol. Behav. 2019, 199, 100–110. [Google Scholar] [CrossRef]
  6. Halevas, E. Encapsulation of flavonoid quercetin in PEGylated SiO2 nanoparticles against Cu (II)-induced oxidative stress. Hell. J. Nucl. Med. 2017, 20, 156–168. [Google Scholar]
  7. Aytac, Z.; Kusku, S.I.; Durgun, E.; Uyar, T. Quercetin/β-cyclodextrin inclusion complex embedded nanofibres: Slow release and high solubility. Food Chem. 2016, 197, 864–871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Anandam, S.; Selvamuthukumar, S. Fabrication of cyclodextrin nanosponges for quercetin delivery: Physicochemical characterization, photostability, and antioxidant effects. J. Mater. Sci. 2014, 49, 8140–8153. [Google Scholar] [CrossRef]
  9. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J. Am. Soc. Inf. Sci. Technol. 2006, 57, 359–377. [Google Scholar] [CrossRef] [Green Version]
  10. Liao, H.; Tang, M.; Luo, L.; Li, C.; Chiclana, F.; Zeng, X.J. A bibliometric analysis and visualization of medical big data research. Sustainability 2018, 10, 166. [Google Scholar] [CrossRef]
  11. Tejada, S.; Nabavi, S.M.; Capo, X.; Martorell, M.; Bibiloni, M.D.; Tur, J.A.; Pons, A.; Sureda, A. Quercetin Effects on Exercise Induced Oxidative Stress and Inflammation. Curr. Org. Chem. 2017, 21, 348–356. [Google Scholar] [CrossRef]
  12. Lesjak, M.; Beara, I.; Simin, N.; Pintac, D.; Majkic, T.; Bekvalac, K.; Orcic, D.; Mimica-Dukic, N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods 2018, 40, 68–75. [Google Scholar] [CrossRef]
  13. Kobori, M.; Takahashi, Y.; Akimoto, Y.; Sakurai, M.; Matsunaga, I.; Nishimuro, H.; Ippoushi, K.; Oike, H.; Ohnishi-Kameyama, M. Chronic high intake of quercetin reduces oxidative stress and induces expression of the antioxidant enzymes in the liver and visceral adipose tissues in mice. J. Funct. Foods 2015, 15, 551–560. [Google Scholar] [CrossRef]
  14. Belen Granado-Serrano, A.; Angeles Martin, M.; Bravo, L.; Goya, L.; Ramos, S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38. Chem. Biol. Interact. 2012, 195, 154–164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Kinaci, M.K.; Erkasap, N.; Kucuk, A.; Koken, T.; Tosun, M. Effects of quercetin on apoptosis, NF-κB and NOS gene expression in renal ischemia/reperfusion injury. Exp. Ther. Med. 2012, 3, 249–254. [Google Scholar] [CrossRef] [PubMed]
  16. Gao, W.N.; Pu, L.L.; Chen, M.; Wei, J.Y.; Xin, Z.H.; Wang, Y.W.; Yao, Z.X.; Shi, T.L.; Guo, C. Glutathione homeostasis is significantly altered by quercetin via the Keapl/Nrf2 and MAPK signaling pathways in rats. J. Clin. Biochem. Nutr. 2018, 62, 56–62. [Google Scholar] [CrossRef]
  17. Ademosun, A.O.; Oboh, G.; Bello, F.; Ayeni, P.O. Antioxidative Properties and Effect of Quercetin and Its Glycosylated Form (Rutin) on Acetylcholinesterase and Butyrylcholinesterase Activities. J. Evid. Based Complement. Altern. Med. 2016, 21, Np11–Np17. [Google Scholar] [CrossRef] [PubMed]
  18. Adedara, I.A.; Ego, V.C.; Subair, T.I.; Oyediran, O.; Farombi, E.O. Quercetin Improves Neurobehavioral Performance through Restoration of Brain Antioxidant Status and Acetylcholinesterase Activity in Manganese-Treated Rats. Neurochem. Res. 2017, 42, 1219–1229. [Google Scholar] [CrossRef] [PubMed]
  19. Chen, B.H.; Park, J.H.; Ahn, J.H.; Cho, J.H.; Kim, I.H.; Lee, J.C.; Won, M.H.; Lee, C.H.; Hwang, I.K.; Kim, J.D.; et al. Pretreated quercetin protects gerbil hippocampal CA1 pyramidal neurons from transient cerebral ischemic injury by increasing the expression of antioxidant enzymes. Neural Regen. Res. 2017, 12, 220–227. [Google Scholar] [PubMed]
  20. Braun, K.F.; Ehnert, S.; Freude, T.; Egana, J.T.; Schenck, T.L.; Buchholz, A.; Schmitt, A.; Siebenlist, S.; Schyschka, L.; Neumaier, M.; et al. Quercetin protects primary human osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes HO-1 and SOD-1. Sci. World J. 2011, 11, 2348–2357. [Google Scholar] [CrossRef]
  21. Akkoyun, D.C.; Akyuz, A.; Dogan, M.; Erboga, M.; Aktas, C.; Caglar, V.; Uygur, R.; Topcu, B.; Yilmaz, A.; Gurel, A. Quercetin Inhibits Heart Injury in Lipopolysaccharide-induced Endotoxemic Model by Suppressing the Effects of Reactive Oxygen Species. Anal. Quant. Cytopathol. Histopathol. 2016, 38, 183–188. [Google Scholar]
  22. Kawamura, K.; Qi, F.; Kobayashi, J. Potential relationship between the biological effects of low-dose irradiation and mitochondrial ROS production. J. Radiat. Res. 2018, 59, ii91–ii97. [Google Scholar] [CrossRef] [Green Version]
  23. Zhao, Y.; Hu, X.; Liu, Y.; Dong, S.; Wen, Z.; He, W.; Zhang, S.; Huang, Q.; Shi, M. ROS signaling under metabolic stress: Cross-talk between AMPK and AKT pathway. Mol. Cancer 2017, 16, 79. [Google Scholar] [CrossRef] [PubMed]
  24. Jalmi, S.K.; Sinha, A.K. ROS mediated MAPK signaling in abiotic and biotic stress-striking similarities and differences. Front. Plant Sci. 2015, 6, 769. [Google Scholar] [CrossRef]
  25. Stoiber, W.; Obermayer, A.; Steinbacher, P.; Krautgartner, W.D. The role of reactive oxygen species (ROS) in the formation of extracellular traps (ETs) in humans. Biomolecules 2015, 5, 702–723. [Google Scholar] [CrossRef] [PubMed]
  26. Vurusaner, B.; Poli, G.; Basaga, H. Tumor suppressor genes and ROS: Complex networks of interactions. Free Radic. Biol. Med. 2012, 52, 7–18. [Google Scholar] [CrossRef]
  27. Song, Y.; Liu, J.; Zhang, F.; Zhang, J.; Shi, T.; Zeng, Z. Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci. 2013, 92, 1215–1221. [Google Scholar] [CrossRef]
  28. Chen, H.; Lu, C.; Liu, H.; Wang, M.; Zhao, H.; Yan, Y.; Han, L. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Int. Immunopharmacol. 2017, 48, 110–117. [Google Scholar] [CrossRef]
  29. Hung, C.H.; Chan, S.H.; Chu, P.M.; Tsai, K.L. Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation. Mol. Nutr. Food Res. 2015, 59, 1905–1917. [Google Scholar] [CrossRef]
  30. Lu, X.L.; Zhao, C.H.; Yao, X.L.; Zhang, H. Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway. Biomed. Pharmacother. 2017, 85, 658–671. [Google Scholar] [CrossRef]
  31. Chang, H.C.; Yang, Y.R.; Wang, P.S.; Wang, R.Y. Quercetin enhances exercise-mediated neuroprotective effects in brain ischemic rats. Med. Sci. Sports Exerc. 2014, 46, 1908–1916. [Google Scholar] [CrossRef]
  32. Du, L.; Hao, M.; Li, C.; Wu, W.; Wang, W.; Ma, Z.; Yang, T.; Zhang, N.; Isaac, A.T.; Zhu, X.; et al. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-beta2/phosphoinositide 3-kinase/Akt pathway. Mol. Cell. Endocrinol. 2017, 452, 44–56. [Google Scholar] [CrossRef]
  33. Peng, Z.; Gong, X.; Yang, Y.; Huang, L.; Zhang, Q.; Zhang, P.; Wan, R.; Zhang, B. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways. Int. Immunopharmacol. 2017, 52, 281–289. [Google Scholar] [CrossRef]
  34. Jin, Y.; Huang, Z.L.; Li, L.; Yang, Y.; Wang, C.H.; Wang, Z.T.; Ji, L.L. Quercetin attenuates toosendanin-induced hepatotoxicity through inducing the Nrf2/GCL/GSH antioxidant signaling pathway. Acta Pharmacol. Sin. 2019, 40, 75. [Google Scholar] [CrossRef] [PubMed]
  35. Zhu, M.; Zhou, X.; Zhao, J. Quercetin prevents alcohol-induced liver injury through targeting of PI3K/Akt/nuclear factor-κB and STAT3 signaling pathway. Exp. Ther. Med. 2017, 14, 6169–6175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Ji, L.L.; Sheng, Y.C.; Zheng, Z.Y.; Shi, L.; Wang, Z.T. The involvement of p62-Keap1-Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicity. Free Radic. Biol. Med. 2015, 85, 12–23. [Google Scholar] [CrossRef]
  37. Dong, Q.H.; Chen, L.; Lu, Q.W.; Sharma, S.; Li, L.; Morimoto, S.; Wang, G.Y. Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. Br. J. Pharmacol. 2014, 171, 4440–4454. [Google Scholar] [CrossRef] [Green Version]
  38. Ma, J.Q.; Li, Z.; Xie, W.R.; Liu, C.M.; Liu, S.S. Quercetin protects mouse liver against CCl(4)-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway. Int. Immunopharmacol. 2015, 28, 531–539. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, C.M.; Zheng, G.H.; Ming, Q.L.; Sun, J.M.; Cheng, C. Protective effect of quercetin on lead-induced oxidative stress and endoplasmic reticulum stress in rat liver via the IRE1/JNK and PI3K/Akt pathway. Free Radic. Res. 2013, 47, 192–201. [Google Scholar] [CrossRef] [PubMed]
  40. Gupta, R.; Shukla, R.K.; Chandravanshi, L.P.; Srivastava, P.; Dhuriya, Y.K.; Shanker, J.; Singh, M.P.; Pant, A.B.; Khanna, V.K. Protective Role of Quercetin in Cadmium-Induced Cholinergic Dysfunctions in Rat Brain by Modulating Mitochondrial Integrity and MAP Kinase Signaling. Mol. Neurobiol. 2017, 54, 4560–4583. [Google Scholar] [CrossRef] [PubMed]
  41. Pratheeshkumar, P.; Son, Y.O.; Divya, S.P.; Wang, L.; Turcios, L.; Roy, R.V.; Hitron, J.A.; Kim, D.; Dai, J.; Asha, P.; et al. Quercetin inhibits Cr (VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget 2017, 8, 52118–52131. [Google Scholar] [CrossRef] [PubMed]
  42. Dong, F.; Wang, S.; Wang, Y.; Yang, X.; Jiang, J.; Wu, D.; Qu, X.; Fan, H.; Yao, R. Quercetin ameliorates learning and memory via the Nrf2-ARE signaling pathway in d-galactose-induced neurotoxicity in mice. Biochem. Biophys. Res. Commun. 2017, 491, 636–641. [Google Scholar] [CrossRef]
  43. Wattel, A.; Kamel, S.; Prouillet, C.; Petit, J.P.; Lorget, F.; Offord, E.; Brazier, M. Flavonoid quercetin differentiation decreases osteoclastic induced by RANKL via a mechanism involving NF-κB and AP-1. J. Cell. Biochem. 2004, 92, 285–295. [Google Scholar] [CrossRef]
  44. Jin, X.; Su, R.; Li, R.; Song, L.; Chen, M.; Cheng, L.; Li, Z. Amelioration of particulate matter-induced oxidative damage by vitamin c and quercetin in human bronchial epithelial cells. Chemosphere 2016, 144, 459–466. [Google Scholar] [CrossRef]
  45. Casagrande, R.; Georgetti, S.R.; Verri, W.A.; Dorta, D.J.; dos Santos, A.C.; Fonseca, M.J.V. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J. Photochem. Photobiol. B 2006, 84, 21–27. [Google Scholar] [CrossRef] [PubMed]
  46. Zhu, X.B.; Li, N.; Wang, Y.L.; Ding, L.; Chen, H.J.; Yu, Y.H.; Shi, X.J. Protective effects of quercetin on UVB irradiation-induced cytotoxicity through ROS clearance in keratinocyte cells. Oncol. Rep. 2017, 37, 209–218. [Google Scholar] [CrossRef] [PubMed]
  47. Zerin, T.; Kim, Y.S.; Hong, S.Y.; Song, H.Y. Quercetin reduces oxidative damage induced by paraquat via modulating expression of antioxidant genes in A549 cells. J. Appl. Toxicol. 2013, 33, 1460–1467. [Google Scholar] [CrossRef] [PubMed]
  48. Hu, X.T.; Ding, C.; Zhou, N.; Xu, C. Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo. Eur. J. Pharmacol. 2015, 754, 115–124. [Google Scholar] [CrossRef]
  49. Tvrda, E.; Tusimova, E.; Kovacik, A.; Paal, D.; Libova, L.; Lukac, N. Protective Effects of Quercetin on Selected Oxidative Biomarkers in Bovine Spermatozoa Subjected to Ferrous Ascorbate. Reprod. Domest. Anim. 2016, 51, 524–537. [Google Scholar] [CrossRef]
  50. Kale, A.; Pişkin, Ö.; Baş, Y.; Aydın, B.G.; Can, M.; Elmas, Ö.; Büyükuysal, Ç. Neuroprotective effects of Quercetin on radiation-induced brain injury in rats. J. Radiat. Res. 2018, 59, 404–410. [Google Scholar] [CrossRef] [Green Version]
  51. Zargar, S.; Siddiqi, N.J.; Ansar, S.; Alsulaimani, M.S.; El Ansary, A.K. Therapeutic role of quercetin on oxidative damage induced by acrylamide in rat brain. Pharm. Biol. 2016, 54, 1763–1767. [Google Scholar] [CrossRef] [PubMed]
  52. Ola, M.S.; Ahmed, M.M.; Shams, S.; Al-Rejaie, S.S. Neuroprotective effects of quercetin in diabetic rat retina. Saudi J. Biol. Sci. 2017, 24, 1186–1194. [Google Scholar] [CrossRef] [PubMed]
  53. Heo, H.J.; Lee, C.Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J. Agric. Food Chem. 2004, 52, 7514–7517. [Google Scholar] [CrossRef] [PubMed]
  54. Zargar, S.; Siddiqi, N.J.; Al Daihan, S.K.; Wani, T.A. Protective effects of quercetin on cadmium fluoride induced oxidative stress at different intervals of time in mouse liver. Acta Biochim. Pol. 2015, 62, 207–213. [Google Scholar] [CrossRef] [PubMed]
  55. Patil, S.L.; Rao, N.B.; Somashekarappa, H.M.; Rajashekhar, K.P. Antigenotoxic potential of rutin and quercetin in Swiss mice exposed to gamma radiation. Biomed. J. 2014, 37, 305–313. [Google Scholar] [CrossRef] [PubMed]
  56. Ozyurt, H.; Cevik, O.; Ozgen, Z.; Ozden, A.S.; Cadirci, S.; Elmas, M.A.; Ercan, F.; Goren, M.Z.; Sener, G. Quercetin protects radiation-induced DNA damage and apoptosis in kidney and bladder tissues of rats. Free Radic. Res. 2014, 48, 1247–1255. [Google Scholar] [CrossRef]
  57. Patil, S.L.; Mallaiah, S.H.; Patil, R.K. Antioxidative and radioprotective potential of rutin and quercetin in Swiss albino mice exposed to gamma radiation. J. Med. Phys. 2013, 38, 87–92. [Google Scholar] [CrossRef] [PubMed]
  58. Kalantari, H.; Foruozandeh, H.; Khodayar, M.J.; Siahpoosh, A.; Saki, N.; Kheradmand, P. Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice. J. Tradit. Complement. Med. 2018, 81, 120–127. [Google Scholar] [CrossRef] [PubMed]
  59. Prasad, J.; Baitharu, I.; Sharma, A.K.; Dutta, R.; Prasad, D.; Singh, S.B. Quercetin reverses hypobaric hypoxia-induced hippocampal neurodegeneration and improves memory function in the rat. High Alt. Med. Biol. 2013, 14, 383–394. [Google Scholar] [CrossRef]
  60. Yarahmadi, A.; Zal, F.; Bolouki, A. Protective effects of quercetin on nicotine induced oxidative stress in ‘HepG2 cells’. Toxicol. Mech. Methods 2017, 27, 609–614. [Google Scholar] [CrossRef]
  61. Chen, X.; Yin, O.Q.P.; Zuo, Z.; Chow, M.S.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm. Res. 2005, 22, 892–901. [Google Scholar] [CrossRef] [PubMed]
  62. Roy, S.; Banerjee, S.; Chakraborty, T. Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events. Biometals 2018, 31, 647–671. [Google Scholar] [CrossRef] [PubMed]
  63. Bratu, M.; Birghila, S.; Miresan, H.; Negreanu-Pirjol, T.; Prajitura, C.; Calinescu, M. Biological Activities of Zn (II) and Cu (II) Complexes with Quercetin and Rutin: Antioxidant Properties and UV-Protection Capacity. Rev. Chim. 2014, 65, 544–549. [Google Scholar]
  64. Bukhari, S.B.; Memon, S.; Mahroof-Tahir, M.; Bhanger, M.I. Synthesis, characterization and antioxidant activity copper-quercetin complex. Spectrochim. Acta Part A 2009, 71, 1901–1906. [Google Scholar] [CrossRef] [PubMed]
  65. Ghosh, N.; Chakraborty, T.; Mallick, S.; Mana, S.; Singha, D.; Ghosh, B.; Roy, S. Synthesis, characterization and study of antioxidant activity of quercetin-magnesium complex. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2015, 151, 807–813. [Google Scholar] [CrossRef] [PubMed]
  66. Raza, A.; Xu, X.; Xia, L.; Xia, C.; Tang, J.; Ouyang, Z. Quercetin-Iron Complex: Synthesis, Characterization, Antioxidant, DNA Binding, DNA Cleavage, and Antibacterial Activity Studies. J. Fluoresc. 2016, 26, 2023–2031. [Google Scholar] [CrossRef]
  67. Roy, S.; Das, R.; Ghosh, B.; Chakraborty, T. Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer. Mol. Carcinog. 2018, 57, 700–721. [Google Scholar] [CrossRef] [PubMed]
  68. Trifunschi, S.; Ardelean, D. Synthesis, Characterization and Antioxidant Activity of Co (II) and Cd (II) Complexes with Quercetin. Rev. Chim. 2016, 67, 2422–2424. [Google Scholar]
  69. Simoes, V.D.; Favarin, L.R.V.; Cabeza, N.A.; de Oliveira, T.D.; Fiorucci, A.R.; Stropa, J.M.; Rodrigues, D.C.M.; Cavalheiro, A.A.; dos Anjos, A. Synthesis, characterization and study of the properties of a new mononuclear quercetin complex containing Ga (III) ions. Quim. Nova 2013, 36, 495–501. [Google Scholar]
  70. Zhou, J.; Wang, L.F.; Wang, J.Y.; Tang, N. Synthesis, characterization, antioxidative and antitumor activities of solid quercetin rare earth (III) complexes. J. Inorg. Biochem. 2001, 83, 41–48. [Google Scholar] [CrossRef]
  71. Ravichandran, R.; Rajendran, M.; Devapiriam, D. Structural characterization and physicochemical properties of quercetin-Pb complex. J. Coord. Chem. 2014, 67, 1449–1462. [Google Scholar] [CrossRef]
  72. Ezzati Nazhad Dolatabadi, J.; Mokhtarzadeh, A.; Ghareghoran, S.M.; Dehghan, G. Synthesis, Characterization and Antioxidant Property of Quercetin-Tb (III) Complex. Adv. Pharm. Bull. 2014, 4, 101–104. [Google Scholar] [PubMed]
  73. Xu, X.R.; Yu, H.T.; Yang, Y.; Hang, L.; Yang, X.W.; Ding, S.H. Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway. Eur. J. Pharmacol. 2016, 770, 1–8. [Google Scholar] [CrossRef] [PubMed]
  74. Singh, D.; Rawat, M.S.; Semalty, A.; Semalty, M. Quercetin-phospholipid complex: An amorphous pharmaceutical system in herbal drug delivery. Curr. Drug Discov. Technol. 2012, 9, 17–24. [Google Scholar] [CrossRef] [PubMed]
  75. Oliver, S.; Yee, E.; Kavallaris, M.; Vittorio, O.; Boyer, C. Water Soluble Antioxidant Dextran-Quercetin Conjugate with Potential Anticancer Properties. Macromol. Biosci. 2018, 18, e1700239. [Google Scholar] [CrossRef] [PubMed]
  76. Patra, M.; Mukherjee, R.; Banik, M.; Dutta, D.; Begum, N.A.; Basu, T. Calcium phosphate-quercetin nanocomposite (CPQN): A multi-functional nanoparticle having pH indicating, highly fluorescent and anti-oxidant properties. Colloids Surf. B. Biointerfaces 2017, 154, 63–73. [Google Scholar] [CrossRef] [PubMed]
  77. Guo, Y.J.; Yang, F.; Zhang, L.; Pi, J.; Cai, J.Y.; Yang, P.H. Facile synthesis of multifunctional germanium nanoparticles as a carrier of quercetin to achieve enhanced biological activity. Chem. Asian J. 2014, 9, 2272–2280. [Google Scholar] [CrossRef] [PubMed]
  78. Matschke, V.; Theiss, C.; Matschke, J. Oxidative stress: The lowest common denominator of multiple diseases. Neural Regen. Res. 2019, 14, 238–241. [Google Scholar] [CrossRef] [PubMed]
  79. Tan, B.L.; Norhaizan, M.E.; Liew, W.P.; Sulaiman Rahman, H. Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases. Front. Pharmacol. 2018, 9, 1162. [Google Scholar] [CrossRef]
  80. Lubrano, V.; Balzan, S. Enzymatic antioxidant system in vascular inflammation and coronary artery disease. World J. Exp. Med. 2015, 5, 218–224. [Google Scholar] [CrossRef]
  81. Rodrigo, R.; Miranda, A.; Vergara, L. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin. Chim. Acta 2011, 412, 410–424. [Google Scholar] [CrossRef] [PubMed]
  82. Maurya, A.K.; Vinayak, M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol. Biol. Rep. 2015, 42, 1419–1429. [Google Scholar] [CrossRef] [PubMed]
  83. Maurya, A.K.; Vinayak, M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): Key role of quercetin in cancer prevention. Tumour Biol. 2015, 36, 8913–8924. [Google Scholar] [CrossRef] [PubMed]
  84. Sharmila, G.; Athirai, T.; Kiruthiga, B.; Senthilkumar, K.; Elumalai, P.; Arunkumar, R.; Arunakaran, J. Chemopreventive effect of quercetin in MNU and testosterone induced prostate cancer of Sprague-Dawley rats. Nutr. Cancer 2014, 66, 38–46. [Google Scholar] [CrossRef] [PubMed]
  85. Sharmila, G.; Bhat, F.A.; Arunkumar, R.; Elumalai, P.; Raja Singh, P.; Senthilkumar, K.; Arunakaran, J. Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model. Clin. Nutr. 2014, 33, 718–726. [Google Scholar] [CrossRef] [PubMed]
  86. Ali, H.; Dixit, S. Quercetin attenuates the development of 7, 12-dimethyl benz (a) anthracene (DMBA) and croton oil-induced skin cancer in mice. J. Biomed. Res. 2015, 29, 139–144. [Google Scholar] [PubMed]
  87. Li, B.; Yang, M.; Liu, J.W.; Yin, G.T. Protective mechanism of quercetin on acute myocardial infarction in rats. Genet. Mol. Res. 2016, 15, 15017117. [Google Scholar] [CrossRef] [PubMed]
  88. Jing, Z.H.; Wang, Z.R.; Li, X.J.; Li, X.T.; Cao, T.T.; Bi, Y.; Zhou, J.C.; Chen, X.; Yu, D.Q.; Zhu, L.; et al. Protective Effect of Quercetin on Posttraumatic Cardiac Injury. Sci. Rep. 2016, 6, 30812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Mehta, V.; Parashar, A.; Udayabanu, M. Quercetin prevents chronic unpredictable stress induced behavioral dysfunction in mice by alleviating hippocampal oxidative and inflammatory stress. Physiol. Behav. 2017, 171, 69–78. [Google Scholar] [CrossRef]
  90. Holzmann, I.; da Silva, L.M.; Correa da Silva, J.A.; Steimbach, V.M.; de Souza, M.M. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways. Pharmacol. Biochem. Behav. 2015, 136, 55–63. [Google Scholar] [CrossRef]
  91. Sherif, I.O. Uroprotective mechanism of quercetin against cyclophosphamide-induced urotoxicity: Effect on oxidative stress and inflammatory markers. J. Cell. Biochem. 2018, 119, 7441–7448. [Google Scholar] [CrossRef] [PubMed]
  92. Maksymchuk, O.; Shysh, A.; Rosohatska, I.; Chashchyn, M. Quercetin prevents type 1 diabetic liver damage through inhibition of CYP2E1. Pharmacol. Rep. 2017, 69, 1386–1392. [Google Scholar] [CrossRef] [PubMed]
  93. Adedara, I.A.; Subair, T.I.; Ego, V.C.; Oyediran, O.; Farombi, E.O. Chemoprotective role of quercetin in manganese-induced toxicity along the brain-pituitary-testicular axis in rats. Chem. Biol. Interact. 2017, 263, 88–98. [Google Scholar] [CrossRef] [PubMed]
  94. Taslidere, E.; Dogan, Z.; Elbe, H.; Vardi, N.; Cetin, A.; Turkoz, Y. Quercetin protection against ciprofloxacin induced liver damage in rats. Biotech. Histochem. 2016, 91, 116–121. [Google Scholar] [CrossRef] [PubMed]
  95. Wang, J.; Miao, M.; Zhang, Y.; Liu, R.; Li, X.; Cui, Y.; Qu, L. Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation. Can. J. Physiol. Pharmacol. 2015, 93, 427–433. [Google Scholar] [CrossRef] [PubMed]
  96. Unsal, C.; Kanter, M.; Aktas, C.; Erboga, M. Role of quercetin in cadmium-induced oxidative stress, neuronal damage, and apoptosis in rats. Toxicol. Ind. Health 2015, 31, 1106–1115. [Google Scholar] [CrossRef] [PubMed]
  97. Olayinka, E.T.; Ore, A.; Adeyemo, O.A.; Ola, O.S.; Olotu, O.O.; Echebiri, R.C. Quercetin, a Flavonoid Antioxidant, Ameliorated Procarbazine-Induced Oxidative Damage to Murine Tissues. Antioxidants 2015, 4, 304–321. [Google Scholar] [CrossRef] [Green Version]
  98. Jahan, S.; Iftikhar, N.; Ullah, H.; Rukh, G.; Hussain, I. Alleviative effect of quercetin on rat testis against arsenic: A histological and biochemical study. Syst. Biol. Reprod. Med. 2015, 61, 89–95. [Google Scholar] [CrossRef] [PubMed]
  99. Huang, R.S.; Zhong, T.; Wu, H. Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress. Arch. Med. Sci. 2015, 11, 427–432. [Google Scholar] [CrossRef] [Green Version]
  100. Almaghrabi, O.A. Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney. Saudi J. Biol. Sci. 2015, 22, 227–231. [Google Scholar] [CrossRef]
  101. Yazici, S.; Ozcan, C.U.; Hismiogullari, A.A.; Sunay, F.B.; Ozcan, T.; Berksoy, E.A.; Aksoz, E. Protective Effects of Quercetin on Necrotizing Enterocolitis in a Neonatal Rat Model. Am. J. Perinatol. 2018, 35, 434–440. [Google Scholar]
  102. Yao, Z.; Gu, Y.; Zhang, Q.; Liu, L.; Meng, G.; Wu, H.; Xia, Y.; Bao, X.; Shi, H.; Sun, S.; et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur. J. Nutr. 2018. [Google Scholar] [CrossRef] [PubMed]
  103. Veith, C.; Drent, M.; Bast, A.; van Schooten, F.J.; Boots, A.W. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Toxicol. Appl. Pharmacol. 2017, 336, 40–48. [Google Scholar] [CrossRef] [PubMed]
  104. Farrag, Y.; Ide, W.; Montero, B.; Rico, M.; Rodriguez-Llamazares, S.; Barral, L.; Bouza, R. Preparation of starch nanoparticles loaded with quercetin using nanoprecipitation technique. Int. J. Biol. Macromol. 2018, 114, 426–433. [Google Scholar] [CrossRef] [PubMed]
  105. Han, Q.S.; Wang, X.H.; Cai, S.F.; Liu, X.L.; Zhang, Y.F.; Yang, L.; Wang, C.; Yang, R. Quercetin nanoparticles with enhanced bioavailability as multifunctional agents toward amyloid induced neurotoxicity. J. Mater. Chem. B 2018, 6, 1387–1393. [Google Scholar] [CrossRef]
  106. Aghapour, F.; Moghadamnia, A.A.; Nicolini, A.; Kani, S.N.M.; Barari, L.; Morakabati, P.; Rezazadeh, L.; Kazemi, S. Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem. Biophys. Res. Commun. 2018, 500, 860–865. [Google Scholar] [CrossRef] [PubMed]
  107. Vijayakumar, A.; Baskaran, R.; Jang, Y.S.; Oh, S.H.; Yoo, B.K. Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake. AAPS PharmSciTech 2017, 18, 875–883. [Google Scholar] [CrossRef]
  108. Patra, A.; Satpathy, S.; Shenoy, A.K.; Bush, J.A.; Kazi, M.; Hussain, M.D. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int. J. Nanomed. 2018, 13, 2869–2881. [Google Scholar] [CrossRef]
  109. Ahmad, N.; Ahmad, R.; Naqvi, A.A.; Alam, M.A.; Ashafaq, M.; Abdur Rub, R.; Ahmad, F.J. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia. Artif. Cells Nanomed. Biotechnol. 2018, 46, 717–729. [Google Scholar] [CrossRef]
  110. Ramadon, D.; Anwar, E.; Harahap, Y. In vitro Penetration and Bioavailability of Novel Transdermal Quercetin-loaded Ethosomal Gel. Indian J. Pharm. Sci. 2017, 79, 948–956. [Google Scholar] [CrossRef]
  111. Khor, C.M.; Ng, W.K.; Chan, K.P.; Dong, Y. Preparation and characterization of quercetin/dietary fiber nanoformulations. Carbohydr. Polym. 2017, 161, 109–117. [Google Scholar] [CrossRef] [PubMed]
  112. Huang, J.; Wang, Q.; Li, T.; Xia, N.; Xia, Q. Nanostructured lipid carrier (NLC) as a strategy for encapsulation of quercetin and linseed oil: Preparation and in vitro characterization studies. J. Food Eng. 2017, 215, 1–12. [Google Scholar] [CrossRef]
Molecules 24 01123 g001 550
Figure 1. Structure and bibliometric results of quercetin. (a) Chemical structure of quercetin. (b) 3D conformer of quercetin. (c) Co-occurrence map of quercetin. The figure is based on data in the Web of Science (WOS) database ranging from 2000 to 2017, and was drawn by CiteSpace. The diameter of a node represents the number of occurrences of keywords. The larger the diameter, the greater the number of appearances.
Figure 1. Structure and bibliometric results of quercetin. (a) Chemical structure of quercetin. (b) 3D conformer of quercetin. (c) Co-occurrence map of quercetin. The figure is based on data in the Web of Science (WOS) database ranging from 2000 to 2017, and was drawn by CiteSpace. The diameter of a node represents the number of occurrences of keywords. The larger the diameter, the greater the number of appearances.
Molecules 24 01123 g001
Molecules 24 01123 g002 550
Figure 2. The antioxidant signaling pathway regulated by quercetin. Environmental factors increase the production of reactive oxygen species (ROS). The mitochondrial electron transport chain (mito ETC) is another robust source of intracellular ROS generation. Quercetin can regulate the enzyme-mediated antioxidant defense system and the non-enzyme-dependent antioxidant defense system. It can also regulate signal pathways such as NRFB, AMPK, and MAPK caused by ROS to promote the antioxidant defense system and maintain oxidative balance. ROS in turn enhance the production of APE1/Ref1 and the activation of several signaling events including p53-mediated apoptotic events, MAPK pathways, the NF-E2-related factor (NRF2)-mediated activation of genes containing antioxidant response element (ARE), and NF-κB [22,23,24,25,26].
Figure 2. The antioxidant signaling pathway regulated by quercetin. Environmental factors increase the production of reactive oxygen species (ROS). The mitochondrial electron transport chain (mito ETC) is another robust source of intracellular ROS generation. Quercetin can regulate the enzyme-mediated antioxidant defense system and the non-enzyme-dependent antioxidant defense system. It can also regulate signal pathways such as NRFB, AMPK, and MAPK caused by ROS to promote the antioxidant defense system and maintain oxidative balance. ROS in turn enhance the production of APE1/Ref1 and the activation of several signaling events including p53-mediated apoptotic events, MAPK pathways, the NF-E2-related factor (NRF2)-mediated activation of genes containing antioxidant response element (ARE), and NF-κB [22,23,24,25,26].
Molecules 24 01123 g002
Molecules 24 01123 g003 550
Figure 3. Basic principle of antioxidant activity of quercetin [78,79,80,81].
Figure 3. Basic principle of antioxidant activity of quercetin [78,79,80,81].
Molecules 24 01123 g003
Table
Table 1. Mechanisms of quercetin for treating damage induced by various factors.
Table 1. Mechanisms of quercetin for treating damage induced by various factors.
Inductive FactorsDamage NameProtection MechanismsResult
LPS/d-GalNAcute liver injuryInhibits the activation of NF-κB and MAPK signaling pathways and inhibits the expression of apoptosis-related proteins induced by LPS/d-GalNDecreases the production of LPS/d-GalN induced by oxidation markers [33]
ToosendaninLiver toxicityInduces Nrf2/GCL/GSH antioxidant signal transduction pathwaysIncreases Nrf2-mediated GCLC/GCLM expression, thereby increasing GSH content in cells [34]
AlcoholLiver damageRegulates phosphoinositide 3-kinase/Akt/NF-κB and STAT3 pathwaysEnhances the body’s antioxidant, anti-inflammatory, and anti-apoptotic effects [35]
A variety of liver toxinsLiver toxicityInduces p62 expression and inhibits the binding of Keap1 and Nrf2Increases the transcription expression of Nrf2-targeted antioxidant genes [36]
DoxorubicinHeart toxicityUpregulates Bmi-1 expression to reduce oxidative stressReduces DNA damage at ROS levels and maintains cardiomyocyte viability [37]
CCl4Liver damageImproves antioxidant activity and regulates TLR2/TLR4 and MAPK/NF-κB signaling pathwaysInhibits ROS production in the liver and attenuates CCl4-induced oxidative damage [38]
LeadLiver damageReduces oxidative stress in liver, inhibits JNK phosphorylation, and increases PI3K and Akt levelsEffectively inhibits lead-induced endoplasmic reticulum stress [39]
CadmiumCerebral cholinergic dysfunctionReduces the production of ROS and protects the integrity of the line by regulating the protein involved in apoptosis and MAPK signal conductionRegulates molecular targets involved in the signal conduction of brain cholinergic energy and reduces the neurotoxicity of cadmium [40]
Malignant cell transformationProtects BEAS-2B cells from Cr (VI) induction by targeting miR-21-PDCD4 signalingReduces ROS production induced by Cr (VI) exposure in BEAS-2B cells [41]
d-lactoseCognitive impairment and neuron degeneration or lossImproves the Nrf2-ARE signaling pathwayDecreases free radicals, increases antioxidant enzyme activity, improves overall antioxidant capacity, and slows down aging by improving Nrf2 [42]
Receptor activator for NF-κB ligandOsteoblast differentiationRegulates the transcription activities of NF-κB and AP-1Inhibits the NF-κB and AP-1 mechanism activation [43]

Share and Cite

MDPI and ACS Style

Xu, D.; Hu, M.-J.; Wang, Y.-Q.; Cui, Y.-L. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules 2019, 24, 1123. https://doi.org/10.3390/molecules24061123

AMA Style

Xu D, Hu M-J, Wang Y-Q, Cui Y-L. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules. 2019; 24(6):1123. https://doi.org/10.3390/molecules24061123

Chicago/Turabian Style

Xu, Dong, Meng-Jiao Hu, Yan-Qiu Wang, and Yuan-Lu Cui. 2019. "Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application" Molecules 24, no. 6: 1123. https://doi.org/10.3390/molecules24061123

Article Metrics

Back to TopTop